Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/5751
Title: | New insights into the pathogenesis of intradialytic hypertension | Authors: | Hajal, Joelle Saliba, Youakim Joubran, Najat Sleilaty, Ghassan Chacra, Dima Assaad, Shafika Chelala, Dania Farès, Nassim |
Affiliations: | Faculty of Medicine | Keywords: | Blood pressure Endothelial dysfunction Hemodialysis Intradialytic hypertension Kidney Nitric oxide |
Issue Date: | 2018-01-01 | Part of: | Open Urology and Nephrology Journal | Volume: | 11 | Issue: | 1 | Start page: | 87 | End page: | 99 | Abstract: | Background: Intradialytic hypertension is identified as an independent predictor of adverse clinical outcome in hemodialysis patients. Little is known about its pathophysiological mechanism. Objective: The aim of this study is to provide new insights into the mechanisms underlying this arterial pressure dysregulation. Methods: 62 subjects on chronic hemodialysis were included in this study. Blood pressure was monitored before, during and following each dialysis session for a 3-month period. Pre- and post-dialysis blood samples were drawn from all the subjects to perform immunoassays, monocyte extractions and western blot analyses. Results: Blood pressure values separated the subjects with in two groups: normal blood pressure (n=53) and intradialytic hypertension (n=9) groups. Renin, angiotensin converting enzyme I and aldosterone plasma concentrations significantly diverged between the groups. Vascular endothelial nitric oxide assessment revealed significantly lower plasma L-citrulline and angiotensin-converting enzyme II in post-dialysis intradialytic hypertensive patients, along with high endothelin I and asymmetric dimethylarginine concentrations. Plasma collectrin levels were significantly higher in pre and post-dialysis intradialytic hypertensive group compared to a normal blood pressure group. Post-dialysis interleukin 6 was significantly higher in intradialytic hypertensive group compared to normal blood pressure group. Finally, pre-dialysis intradialytic hypertension was associated with significantly higher circulating vascular endothelial growth factor C with monocytic up-regulation of vascular endothelial growth factor C/tonicity-responsive enhancer binding protein expression. Conclusion: Impairment of vascular endothelial nitric oxide key regulatory elements, as well as monocytic vascular endothelial growth factor C seems to be more prevalent in intradialytic hypertension. These clues could pinpoint novel therapeutic interventions in intradialytic hypertension management. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/5751 | DOI: | 10.2174/1874303X01811010087 | Open URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Faculty of Medicine |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.